← Back to Search

Continuous Glucose Monitoring Device

DEXCOM G6 CGM for Diabetic Ketoacidosis

N/A
Waitlist Available
Led By Magdalena Bogun, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 20 days
Awards & highlights
No Placebo-Only Group

Summary

This trial investigates using the DEXCOM G6 device to continuously monitor blood sugar levels in patients with a specific type of diabetes. The goal is to see if these patients can be safely treated outside intensive care, reducing the need for frequent blood sugar tests. The Dexcom G6 provides real-time glucose data to help patients manage their condition more effectively.

Eligible Conditions
  • Diabetic Ketoacidosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 20 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 20 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Time to Resolution of Metabolic Acidosis
Secondary study objectives
Cost savings
Length of Hospital Stay
Length of ICU Stay
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: DEXCOM G6 CGMExperimental Treatment1 Intervention
Continuous glucose monitoring by DEXCOM G6 (glucose monitoring device) in a step-down unit in participants with DKA
Group II: Hourly Finger Stick Point of Care (Historical Control)Active Control1 Intervention
Retrospective chart review of DKA patients that received hourly glucose monitoring by finger stick while in the ICU

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,486 Previous Clinical Trials
2,663,082 Total Patients Enrolled
DexCom, Inc.Industry Sponsor
144 Previous Clinical Trials
35,387 Total Patients Enrolled
Magdalena Bogun, MDPrincipal InvestigatorColumbia University
~29 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top